Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
TOPIC FOR GENERAL KNOWLEDGE & GENERAL AWARENESS Facts about India India's…
Public Health Initiatives by Takeda to Strengthen Health System for Rare Diseases i…
1. INTRODUCTION The lychee (Litchi chinensis Sonn) an important sub-tropical …